Mar 01, 2018

Mr. Shohat Was Nominated as The Chairman of The BOD.

Lyra medical announced that Mr. Shaul Shohat in nominated as a chairman and the Board of Directors.

Binyamina, Israel, March 1st, 2018 – an Israeli medical device company Lyra Medical Ltd, a developer of the anchorless trans-vaginal Self-Retaining Support (SRS) Implant, announced today that Mr. Shaul Shohat was nominated as a chairman of the board of directors.

Mr. Shohat is a serial entrepreneur with over 20 years of experience in entrepreneurship, senior management and development in the medical devices arena. He has been involved in the incorporation of 8 medical device companies. He is the Co-Founder and chairperson of Bio-Protect, a Co-Founder of Eon Surgical Ltd that was acquired by Teleflex Medical and was a co-founder and Chief Technology Officer of OrthoSpace, which was acquired by a US fund. He also serves as Director at Xenolith Medical Ltd and was previously the Vice President of R&D at Bio-Rad Laboratories.

“We are delighted to have a chairman with the caliber and entrepreneurship DNA of Mr. Shohat His vast experience and successful track records will assist Lyra Medical in achieving its business goals” said Iram Levit, Lyra Medical’s CEO.


About Lyra Medical

Lyra Medical was established in 2011 by a team of seasoned medical device entrepreneurs to develop a new and safer organ support implant for women suffering from pelvic organ prolapse (POP).

The company’s Self-Retaining Support (SRS) technology is presently being applied in the flagship Lyra system for anterior vaginal wall, Apex and uterine prolapse. The support platform may be applicable in other pelvic organ disorder conditions, such as rectocele and urinary incontinence, as well as other clinical areas. In all these areas, there is an acute need for therapeutic solutions that deliver exceptional safety and long-term efficacy.